Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Amir Tahmasb Fathi, Omar Ibrahim Abdel-Wahab, Hossein Sadrzadeh, Julia Foster, Meghan Burke, Darrell R. Borger, A. John Iafrate, Sophia Adamia, Suiyang Liu, Karen K. Ballen, Philip C. Amrein, Eyal C. Attar, Kimberly Straley, Katharine Yen, David P. Schenkein, Donna S. Neuberg, Ross L. Levine, Yi-Bin Albert Chen, Richard M. Stone
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2997996235
